(주) 네오젠로직

{
  "address": "경기 성남시",
  "ceo_name": "김상철, 최정균",
  "certificate": [
    {
      "cert_number": "20190300767",
      "changes": "",
      "disclosure_date": "2019-08-22",
      "first_cert_date": "2019-08-22",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2019-08-22 ~ 2021-08-21"
    },
    {
      "cert_number": "20210804010066",
      "changes": "",
      "disclosure_date": "2021-08-04",
      "first_cert_date": "2019-08-22",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-08-22 ~ 2024-08-21"
    },
    {
      "cert_number": "20240807010022",
      "changes": "기업명, 대표자",
      "disclosure_date": "2024-08-07",
      "first_cert_date": "2019-08-22",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-08-22 ~ 2027-08-21"
    }
  ],
  "company_name": "(주) 네오젠로직",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 935985000,
      "cost_of_sales": 124716000,
      "current_assets": 1988979000,
      "current_liabilities": 1617993000,
      "gross_profit": 83384000,
      "net_income": -1160117000,
      "net_income_bs": -1160117000,
      "non_current_assets": 2198124000,
      "non_current_liabilities": 502330000,
      "non_operating_expenses": 0,
      "non_operating_income": 292123000,
      "operating_profit": -1452240000,
      "revenue": 208100000,
      "sga_expenses": 1535624000,
      "total_assets": 4187103000,
      "total_equity": 2066780000,
      "total_liabilities": 2120323000
    },
    "2023": {
      "capital_stock": 935985000,
      "cost_of_sales": 75504000,
      "current_assets": 1301451000,
      "current_liabilities": 3080223000,
      "gross_profit": 124929000,
      "net_income": -1470592000,
      "net_income_bs": -1470592000,
      "non_current_assets": 4004732000,
      "non_current_liabilities": 1629772000,
      "non_operating_expenses": 148632000,
      "non_operating_income": 523330000,
      "operating_profit": -1845290000,
      "revenue": 200433000,
      "sga_expenses": 1970219000,
      "total_assets": 5306183000,
      "total_equity": 596188000,
      "total_liabilities": 4709995000
    },
    "2024": {
      "capital_stock": 935985000,
      "cost_of_sales": 80867000,
      "current_assets": 260590000,
      "current_liabilities": 2982477000,
      "gross_profit": 152013000,
      "net_income": -1312018000,
      "net_income_bs": -1312018000,
      "non_current_assets": 5727890000,
      "non_current_liabilities": 1807233000,
      "non_operating_expenses": 180986000,
      "non_operating_income": 1176359000,
      "operating_profit": -2307391000,
      "revenue": 232880000,
      "sga_expenses": 2459404000,
      "total_assets": 5988480000,
      "total_equity": 1198770000,
      "total_liabilities": 4789710000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2020-03-30"
    },
    {
      "amount": "2,999,000,000",
      "changes": "2,999,000,000",
      "date": "2020-03-02"
    },
    {
      "amount": "2,999,970,908",
      "changes": "2,999,970,908",
      "date": "2020-03-02"
    },
    {
      "amount": "75,000,000",
      "changes": "75,000,000",
      "date": "2019-08-12"
    }
  ],
  "main_products": "기타연구조사서비스",
  "phone": "031-751-****",
  "years": [
    2024,
    2023,
    2022
  ]
}